https://www.selleckchem.com/pr....oducts/Chlorogenic-a
61, P=0.0003). There was no great difference in the incidence of adverse events between the two groups (Z=0.46, P=0.64). No statistical heterogeneity (Chi2 =3.72, I2=0%, P=0.45) and difference (Z=1.57, P=0.12) were found in asthma exacerbation between the two groups. The asthma control questionnaire (ACQ) score of the control group was much lower than that of the experimental group (Z=3.20, P=0.001). Competitive antagonists of CRTH2 could effectively improve FEV1 and lower ACQ scores in patients with asthma, and were therefore
Like
Comment
Share
